Revance's Botox rival gets FDA approval for painful neck muscle condition

2 years ago 23

The U.S. Food and Drug Administration's green light for the application of Revance Therapeutics' Daxxify has elevated the competition between this anti-wrinkle injection and Botox.

1. Homepage
2. National News
3. Revance's Botox rival gets FDA approval for painful neck muscle condition